CLOs on the Move


 
WellGen is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in N Brunswick, NJ. To find more information about WellGen, please visit www.amphioncap.com
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Cascade Regional Blood Services

Cascade Regional Blood Services is a Tacoma, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthcare Bluebook

Healthcare Bluebook`s goal is to protect consumers and companies nationwide from overpriced, low-quality healthcare. Using industry-leading objective price and quality data and claims-driven ROI reporting, Bluebook`s intuitive online healthcare shopping solution provides 7,000+ employers and members with an easy-to-use benefits solution that increases movement to high-value care, driving savings and rapid ROI, and provides greater price predictability. Combined with a proven engagement methodology, Bluebook`s innovative suite of services empowers employees to become smarter healthcare shoppers, while decreasing costs and improving healthcare outcomes.

Community Medical Center, Inc

CMC's Department of Pediatrics and the hospital's administration are committed to quality care for children, said Steve Carlson, CMC's president and chief executive officer.

Spinal Kinetics

Spinal Kinetics is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Sunnyvale, CA. To find more information about Spinal Kinetics, please visit www.spinalkinetics.com

Relievant Medsystems

Relievant Medsystems, Inc., a privately held medical device company pioneering the INTRACEPT therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain (CLBP). The INTRACEPT Intraosseous Nerve Ablation System is a patent-protected, minimally invasive, implant-free therapy that utilizes radiofrequency energy delivered into the vertebral body of the spine to ablate the Basivertebral Nerve (BVN). This nerve, characterized in peer-reviewed literature reporting studies of pain signal transmission and in preclinical and clinical evaluations, is a significant contributor in the transduction of pain arising from degeneration of the vertebral bodies associated with CLBP. The INTRACEPT Intraosseous Nerve Ablation System leverages proprietary instruments and methods to disable this nerve.